Invention Application
- Patent Title: HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS
- Patent Title (中): 用于药物组合物的含有巯基的三烯丙基嘧啶
-
Application No.: US13034913Application Date: 2011-02-25
-
Publication No.: US20110212102A1Publication Date: 2011-09-01
- Inventor: Thorsten LEHMANN-LINTZ , Joerg KLEY , Norbert REDEMANN , Achim SAUER , Leo THOMAS , Dieter WIEDENMAYER , Matthias AUSTEN , John DANILEWICZ , Martin SCHNEIDER , Kay SCHREITER , Phillip BLACK , Wesley BLACKABY , Ian LINNEY
- Applicant: Thorsten LEHMANN-LINTZ , Joerg KLEY , Norbert REDEMANN , Achim SAUER , Leo THOMAS , Dieter WIEDENMAYER , Matthias AUSTEN , John DANILEWICZ , Martin SCHNEIDER , Kay SCHREITER , Phillip BLACK , Wesley BLACKABY , Ian LINNEY
- Applicant Address: DE Ingelheim am Rhein
- Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Current Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Current Assignee Address: DE Ingelheim am Rhein
- Priority: EP10154925.1 20100226
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D495/04 ; C07D498/04 ; A61K31/55 ; A61K31/5377 ; A61K31/56 ; A61K39/395 ; A61P3/10 ; A61P3/00 ; A61P35/00 ; A61P25/28 ; A61P29/00 ; A61P13/12 ; A61P3/06
Abstract:
The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
Public/Granted literature
- US08648068B2 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions Public/Granted day:2014-02-11
Information query
IPC分类:
